Jonathan Zalevsky

Jonathan Zalevsky

Company: Nektar

Job title: Chief Research & Development Officer


Rezpegaldesleukin, a Regulatory T-Cell Selective IL-2 Conjugate: Lessons Learned From Preclinical Design to Clinical Evaluation in Inflammatory Skin Diseases Including Atopic Dermatitis 2:00 pm

Use of the appropriate design elements and experimental models for generation and preclinical evaluation Using clinical development approaches to address target engagement and assess PK/PD principles Using clinical studies to identify the correlation between the MOA and the indicationRead more

day: Day Two PM Non-Cell Based Approaches

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.